Status
Conditions
Treatments
About
Intravenous (IV) tissue plasminogen activator (tPA) is one of the key elements of acute ischemic stroke. In this study, acute stroke patients maximum benefit from the treatment, intravenous tissue plasminogen activator (IV tPA) minimizing the errors related to the treatment of acute ischemic stroke patients of nursing students from clinical practice guides published on the treatment of It is aimed to be informed and to standardize nursing interventions.
Full description
Time management in acute stroke patients is possible with a multidisciplinary approach and team members who have received specific training for acute stroke patients. Studies have shown that the maximum result of treatment for acute stroke patients depends on nurses' ability to identify disease symptoms, plan and apply symptom-specific nursing care. There is evidence that the multidisciplinary presence of stroke teams in stroke units and the delivery of coordinated care during the acute phase improve patient outcomes . Coordinated care by the stroke team improves patient outcomes, reduces hospital costs, reduces patient readmission, and improves patient care quality.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Intern nursing student at Dokuz Eylül University
Exclusion criteria
Those who did not agree to participate in the study Those who were not be intern
Primary purpose
Allocation
Interventional model
Masking
75 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal